Please use this identifier to cite or link to this item:
Type
ArticleCopyright
Restricted access
Collections
- IOC - Artigos de Periódicos [12977]
Metadata
Show full item record
MINOCYCLINE INHIBITS MICROGLIAL ACTIVATION IN THE CA1 HIPPOCAMPAL REGION AND PREVENTS LONG-TERM COGNITIVE SEQUEL AFTER EXPERIMENTAL CEREBRAL MALARIA
Cognitive impairment
Neuroinflammation
Microglial cells
Microglial activation
Minocycline
Author
Affilliation
Abstract
Cerebral malaria is the worst complication of malaria infection, has a high mortality rate, and may cause different neurodysfunctions, including cognitive decline. Neuroinflammation is an important cause of cognitive damage in neurodegenerative diseases, and microglial cells can be activated in a disease-associated profile leading to tissue damage and neuronal death. Here, we demonstrated that treatment with minocycline reduced blood-brain barrier breakdown and modulated ICAM1 mRNA expression; reduced proinflammatory cytokines, such as TNF-α, IL-1β, IFN-γ, and IL-6; and prevented long-term cognitive decline in contextual and aversive memory tasks. Taken together, our data suggest that microglial cells are activated during experimental cerebral malaria, leading to neuroinflammatory events that end up in cognitive damage. In addition, pharmacological modulation of microglial activation, by drugs such as minocycline may be an important therapeutic strategy in the prevention of long-term memory impairment.
Keywords
Cerebral malariaCognitive impairment
Neuroinflammation
Microglial cells
Microglial activation
Minocycline
Share